Mounjaro 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1AZ9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,982
Award facts
- Contract value 100% obligated
- $16,981.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,981.65 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 mL pens on January 29, 2026, with an ultimate completion date of January 30, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with Cencora, Inc. (the parent company operating as AmerisourceBergen) holding the broader Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order is executed under the parent company's significant $999,999,999.00 IDC with DLA through December 2031, which provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally.
This delivery order represents a routine pharmaceutical procurement supporting the Defense Health Agency and other federal military healthcare programs. Mounjaro, a diabetes management medication, falls within the broad therapeutic categories covered under the master IDC vehicle, which encompasses specialty medications, brand-name and generic drugs, vaccines, and associated medical supplies. The firm fixed-price structure and one-day delivery window indicate this is a standard fulfillment against the standing contract authority, reflecting AmerisourceBergen's established role as a critical pharmaceutical distributor for federal military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F1AZ9?
SPE2DR26F1AZ9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F1AZ9 worth?
The government has obligated $16,982 on SPE2DR26F1AZ9.
Is contract SPE2DR26F1AZ9 an order under another contract?
Yes. SPE2DR26F1AZ9 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AZ9 competed?
The extent of competition for SPE2DR26F1AZ9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award